Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia

被引：0
|
作者：
Sirvent, JLG [1 ]
Socas, MMA [1 ]
Calzadilla, CH [1 ]
Lirola, AML [1 ]
Valls, MRA [1 ]
机构：
[1] Hosp Univ Canarias, Lab Serv, Infect Dis Serv, Tenerife, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.qai.0000174650.33159.22
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：111 / 113
页数：3
相关论文
共 50 条
  • [31] Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients
    Delaugerre, Constance
    Gallien, Sebastien
    Flandre, Philippe
    Mathez, Dominique
    Amarsy, Rishma
    Ferret, Samuel
    Timsit, Julie
    Molina, Jean-Michel
    de Truchis, Pierre
    PLOS ONE, 2012, 7 (05):
  • [32] HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western
    Kantor, Rami
    DeLong, Allison
    Schreier, Leeann
    Reitsma, Marissa
    Kemboi, Emanuel
    Orido, Millicent
    Obonge, Salome
    Boinett, Robert
    Rono, Mary
    Emonyi, Wilfred
    Brooks, Katie
    Coetzer, Mia
    Buziba, Nathan
    Hogan, Joseph
    Diero, Lameck
    AIDS, 2018, 32 (17) : 2485 - 2496
  • [33] Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
    Palmer, Sarah
    Malclarelli, Frank
    Wiegand, Ann
    Bernstein, Barry
    Hanna, George J.
    Brun, Scott C.
    Kempf, Dale J.
    Mellors, John W.
    Coffin, John M.
    King, Martin S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) : 3879 - 3884
  • [34] Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia
    Villalobos, Camila
    Elena Ceballos, Maria
    Ferres, Marcela
    Palma, Carlos
    JOURNAL OF CLINICAL VIROLOGY, 2020, 132
  • [35] Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China
    Liu, Jinjin
    Li, Chaofeng
    Sun, Yan
    Fu, Chaohong
    Wei, Shuguang
    Zhang, Xiaohua
    Ma, Jie
    Zhao, Qingxia
    Huo, Yuqi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Low prevalence of detectable HIV plasma viremia in patients treated with antiretroviral therapy in Burkina Faso and Mali
    Boileau, Catherine
    Nguyen, Vinh-Kim
    Sylla, Mohamed
    Machouf, Nima
    Chamberland, Annie
    Traore, Hamar A.
    Niamba, Pascal A.
    Diallo, Ismael
    Maiga, Moussa
    Cisse, Mamadou
    Rashed, Selim
    Tremblay, Cecile
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (04) : 476 - 484
  • [37] HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance
    Nichols, B. E.
    Boucher, C. A. B.
    van de Vijver, D. A. M. C.
    JOURNAL OF INTERNAL MEDICINE, 2011, 270 (06) : 532 - 549
  • [38] Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations
    Palich, R.
    Wirden, M.
    Peytavin, G.
    Le, M. -P
    Seang, S.
    Abdi, B.
    Schneider, L.
    Tubiana, R.
    Valantin, M. A.
    Paccoud, O.
    Soulie, C.
    Calvez, V
    Katlama, C.
    Marcelin, A. G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2981 - 2985
  • [39] Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence
    Rindi, Lorenzo Vittorio
    Zace, Drieda
    Compagno, Mirko
    Colagrossi, Luna
    Santoro, Maria Mercedes
    Andreoni, Massimo
    Perno, Carlo Federico
    Sarmati, Loredana
    SEXUALLY TRANSMITTED INFECTIONS, 2024,
  • [40] Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
    Elvstam, Olof
    Medstrand, Patrik
    Yilmaz, Aylin
    Isberg, Per-Erik
    Gisslen, Magnus
    Bjorkman, Per
    PLOS ONE, 2017, 12 (07):
12345